SEER(Seer, Inc.) · 财务报表

SEER(Seer, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$6.62M$15.49M$16.66M$14.17M$16.58M
毛利润$3.41M$7.09M$8.51M$7.05M$8.46M
营业利润−$71.47M−$97.23M−$103.46M−$100.10M−$77.99M
净利润−$71.17M−$92.97M−$86.28M−$86.60M−$73.60M
经营现金流−$46.35M−$60.78M−$59.06M−$46.11M−$44.45M
自由现金流−$53.27M−$71.05M−$66.37M−$49.69M−$46.24M
摊薄每股收益$-1.17$-1.49$-1.35——

Seer, Inc. SEER